NEW YORK, Nov. 1, 2018 /PRNewswire/ — AAVP Biosystems, Inc. a developmental stage gene delivery company initially focused on the pursuit of a new therapy for cancer indications, is now named PhageNova Bio, Inc. PhageNova Bio’s hybrid vector platform relies on combining the targeting capability of bacteriophage and the […]

AAVP Biosystems, Inc. Now Named PhageNova Bio, Inc. and Renata Pasqualini, PhD, Appointed as Chief Scientific Officer

Related Posts
Company
Subscribe to Updates
Get the latest news from Biotech Metropolitan Women.
Biotech Metropolitan Women ©2018-2023